## Core Concept
Juvenile myoclonic epilepsy (JME) is a type of generalized epilepsy characterized by myoclonic seizures, generalized tonic-clonic seizures, and sometimes absence seizures. It typically starts in adolescence and is a lifelong condition. The underlying pathophysiology involves genetic factors and alterations in neuronal function.

## Why the Correct Answer is Right
The correct answer is related to the characteristics of JME. Typically, JME is associated with:
- Myoclonic seizures (often occurring in the morning)
- Generalized tonic-clonic seizures
- Sometimes absence seizures
- Generalized 3-6 Hz spike-and-wave or polyspike-and-wave discharges on EEG
- Photosensitivity is common

## Why Each Wrong Option is Incorrect
To accurately address this question, the specific options (A, B, C, D) need to be provided. However, given the common characteristics and facts about JME, we can infer that an incorrect statement might relate to:
- **Option A:** If it suggests JME is typically associated with focal seizures, this would be incorrect because JME is a form of generalized epilepsy.
- **Option B:** If it mentions the typical age of onset or specific EEG patterns, an incorrect statement could involve an age range or EEG findings not typical for JME.
- **Option C:** If it implies that JME does not respond to medication, this would be incorrect as many patients with JME respond well to antiepileptic drugs.
- **Option D:** Without specifics, if an option contradicts established knowledge about JME's clinical presentation, genetics, or treatment, it would be incorrect.

## Clinical Pearl / High-Yield Fact
A key point to remember is that **valproate is often the drug of choice for JME** due to its broad-spectrum efficacy against generalized seizures, including myoclonic, tonic-clonic, and absence seizures. Additionally, **photosensitivity** is a hallmark in many patients, which can be a clue to the diagnosis.

## Correct Answer: D.